Cargando…

EPA and Huntington's chorea: treatment and associated cerebral changes

Detalles Bibliográficos
Autor principal:	Puri, Basant K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991937/ http://dx.doi.org/10.1186/1744-859X-9-S1-S27

Ejemplares similares

The pharmacotherapy of depression with EPA
por: Puri, Basant K
Publicado: (2010)

Structural brain changes in patients with Huntington's disease participating in a randomized, double-blind, placebo-controlled trial of ethyl-eicosapentaenoic acid
por: Puri, Basant K, et al.
Publicado: (2010)

The History of Huntington's Chorea
por: Stevens, David L.
Publicado: (1972)

EPA in schizophrenia and violence
por: Treasaden, Ian H
Publicado: (2010)

Upper facial chorea in Huntington disease
por: Fekete, Robert, et al.
Publicado: (2014)

Prevalence of cataract in adult Down's syndrome patients
por: Puri, Basant K, et al.
Publicado: (2010)

Review of deutetrabenazine: a novel treatment for chorea associated with Huntington’s disease
por: Dean, Marissa, et al.
Publicado: (2018)

The structure, biosynthesis and functions of EPA: biomolecular neuropsychiatric aspects
por: Tsaluchidu, Sofia
Publicado: (2010)

The Prevention of Huntington's Chorea: The Milroy Lecture 1985
por: Harper, Peter S.
Publicado: (1986)

Chorea–Acanthocytosis and the Huntington Disease Allele in an Irish Family
por: Murphy, Olwen C., et al.
Publicado: (2018)

EPA and the Perrin Technique: a combined approach to treating myalgic encephalomyelitis
por: Perrin, Raymond
Publicado: (2010)

Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia
por: Puri, Basant K, et al.
Publicado: (2010)

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington’s Disease
por: Burgunder, Jean-Marc, et al.
Publicado: (2011)

Regional grey matter volumetric changes in forensic schizophrenia patients: a magnetic resonance imaging study comparing the brain structure of patients who have seriously and violently offended with those of patients who have not
por: Puri, Basant K, et al.
Publicado: (2010)

Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease
por: Casaca-Carreira, João, et al.
Publicado: (2015)

Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease
por: Coppen, Emma M., et al.
Publicado: (2016)

The EPA/EADS/ESC position statement on diabetes and cardiovascular risk in patients with severe mental disorders
por: Möller, Hans-Jurgen
Publicado: (2010)

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
por: Frank, Samuel
Publicado: (2010)

Brain cell membrane motion-restricted phospholipids in patients with schizophrenia who have seriously and dangerously violently offended
por: Puri, Basant K, et al.
Publicado: (2010)

Chorea and Anemia
por: Miller, Roshier W.
Publicado: (1904)

Quinine in Chorea
Publicado: (1895)

Update on the Non-Huntington's Disease Choreas with Comments on the Current Nomenclature
por: Walker, Ruth H.
Publicado: (2012)

Novel Imaging Biomarkers for Huntington’s Disease and Other Hereditary Choreas
por: Fazio, Patrik, et al.
Publicado: (2018)

Anti-ma2 receptor encephalitis mimicking Huntington chorea
por: Etemadifar, Masoud, et al.
Publicado: (2017)

Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring
por: Kotschet, Katya, et al.
Publicado: (2022)

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)
por: Harris, Kate L, et al.
Publicado: (2020)

A Voice Sign in Chorea
Publicado: (1914)

Anesthetic management of a patient with Huntington's chorea -A case report-
por: Kang, Jong-Man, et al.
Publicado: (2013)

A Case of Huntington's Chorea: Sir Clifford Allbutt's Clinical Lecture
Publicado: (1918)

George Huntington: And His Relationship to the Earlier Descriptions of Chronic Hereditary Chorea
por: De Jong, Russell N.
Publicado: (1937)

Defining Utility Values for Chorea Health States in Patients with Huntington’s Disease
por: Claassen, Daniel O., et al.
Publicado: (2022)

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
por: Frank, Samuel, et al.
Publicado: (2022)

EPA guidance on treatment of cognitive impairment in schizophrenia
por: Vita, A.
Publicado: (2023)

Pharmacological treatment of chorea in Huntington’s disease–good clinical practice versus evidence-based guideline
por: Reilmann, Ralf
Publicado: (2013)

Osmolality changes during mannitol therapy in cerebral oedema
por: Špatenková, V, et al.
Publicado: (2003)

Differential Diagnosis of Chorea—HIV Infection Delays Diagnosis of Huntington’s Disease by Years
por: Achenbach, Jannis, et al.
Publicado: (2021)

Chorea me a river: depression in Huntington’s disease as an exemplar of precision medicine
por: Hannan, Anthony J
Publicado: (2022)

Memantine administration prevented chorea movement in Huntington’s disease: a case report
por: Saigoh, Kazumasa, et al.
Publicado: (2023)

Chorea as the First Manifestation of Cerebral Infarction
por: Hernandez Fustes, Otto Jesus, et al.
Publicado: (2020)

Lumbar Puncture Alleviates Chorea in a Patient with Huntington’s Disease and Normal Pressure Hydrocephalus
por: Shirani, Peyman, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_79bvvjd6impmldusq3mpfsqgg8